Hikma Has A First With Labetalol Launch In US
Also Introduces Hydralazine And Estradiol Valerate As Part Of Latest Injectables Push
Executive Summary
Hikma says it is breaking new ground in the US with a ready-to-use presentation of labetalol. Meanwhile, the company has also added hydralazine to its list of recent injectables launches.